Xiaohong (Sherry) Cao, Ph.D.

Associate Scientific Director, Genzyme Sanofi Corp.
Genzyme Sanofi Science Center

Sherry has over ten years’ experience in genomic research and bioinformatics focusing on genomic data analysis for disease and therapeutic biomarker development.  She spearheaded the genomic & informatics efforts for several critical biomarker planning and development projects within Genzyme, a Sanofi company.  Her research interest focuses on using statistical and network analysis approaches for disease targeting and compound repositioning.  She is an out-of-the-box thinker who can connect the dots between clinical and research programs.  Recently, she has been the scientific lead for a translational data management hub development project to provide a repository for translational research and biomarker research data within Sanofi.

As an Associate Scientific Director at Genzyme, Sherry serves as the translational informatics lead for the translational medicine program within Genzyme and a steering committee member for the Translational Medicine For Patients (TM4P) program within Sanofi.   Prior to Genzyme, she was a postdoctoral fellow at Harvard University where she conducted molecular evolution research in Dr. Wally Gilbert’s lab.  She holds a Ph.D. in biochemistry from Yale University and an MBA from Babson College.